Biotech China 2014

Proteomics: Genentech

Total Score People Score Events Score
25 22 12
Date Event Presentation Speakers
April 6, 2013 AACR Annual Meetings Expanding the Druggable Genome Chairperson: Stephen W. Fesik, Vanderbilt University School of Medicine, Nashville, TN Domagoj Vucic
Mitotic Checkpoints Driving Cancer Therapeutic Strategies Chairperson: Peter K. Jackson, Genentech, Inc., South San Francisco, CA Peter K Jackson
May 19, 2010 Protein Aggregation in Biopharmaceutical Products KEYNOTE PRESENTATION - Proteins, Bad Environment: The Role of Ions in Governing Stability, Solubility, and Viscosity of Proteins Yatin Gokarn
August 26, 2009 Optimizing Mammalian Cell Lines Development of a Novel Double Selection System to Improve Antibody Productivity in CHO Cell Lines Domingos Ng
January 26, 2009 Preclinical Biomarker Discovery and Validation for a Small Molecule Inhibitor of MEK Kinase Mark R Lackner
January 26, 2009 Biomarker Assay Development Preclinical Biomarker Discovery and Validation for a Small Molecule Inhibitor of MEK Kinase Mark R Lackner
January 26, 2009 Translational Cancer Medicine Preclinical Biomarker Discovery and Validation for a Small Molecule Inhibitor of MEK Kinase Mark R Lackner
July 19, 2008 22nd Annual Symposium of The Protein Society Concurrent Afternoon Symposia 9: New Methods for Engineering Recognition Sachdev Sidhu
April 27, 2008 Phage Display of Antibodies and Peptides Chairperson’s Remarks Dev Sidhu
Synthetic Antibodies Germaine Fuh
April 27, 2008 Phage Display of Antibodies and Peptides Synthetic Antibodies Germaine Fuh
October 3, 2007 MAOS 2007 Microwave Assisted Organic Synthesis Congress Microwave-Assisted Proteomics in the Biotechnology Area Wendy Sandoval
September 30, 2007 BioProcess International Conference & Exhibition Scaling Up from Bench through Commercialization , Best Practices for Strategic Scale Up Decisions (07:00 - 12:15) David H. Reifsnyder
Best Practices for Strategic Scale Up Decisions: Evolution of a Process Development Strategy David H. Reifsnyder
Production & Economics of Biopharmaceuticals : Enhancing Operational Excellence and Process Efficiencies (13:45 - 15:30) Mark Skoog
Enhancing Operational Excellence and Process Efficiencies : Fermentation Operational Excellence Mark Skoog
Scaling Up from Bench through Commercialization ; Regulatory and Quality Considerations (13:45 - 17:45) Mary B. Sliwkowski, Markus Gemuend
Regulatory and Quality Considerations : A Biopharmaceutical Industry Perspective on Quality By Design Mary B. Sliwkowski
Regulatory and Quality Considerations : KEYNOTE PRESENTATION; Genentech's Manufacturing Strategy and Vision of Future Needs Markus Gemuend
Scaling Up from Bench through Commercialization ; Scale Down Models, Process Characterization and Validation (08:00 - 12:00) Srikanth R. Chary
Scale Down Models, Process Characterization and Validation : Predictive Scale-Down Models for Cell Culture: Avoiding Pitfalls and Establishing Model Comparability Srikanth R. Chary
Early Stage Process Development - Getting to Clinic Faster (8:15 - 11:30) Amy Shen
Early Stage Process Development - Getting to Clinic Faster : Therapeutic Antibody Production Cell Line Development with an Improved Selection Process and Accelerated Timeline Amy Shen
Cell Culture & Upstream Processing (13:45 - 18:00) David Chang
Cell Culture & Upstream Processing : Evaluation and Impact of Hydrolysates on Production Yield Improvement David Chang
Overcoming the Challenges of the Ton Scale Process : Purification Process Development to Increase Capacity in an Existing Manufacturing Facility Christopher Teske
Recovery & Purification ; Overcoming the Challenges of the Ton Scale Process (13:45 - 16:00) Christopher Teske
Cell Culture & Upstream Processing: Chairperson's Remarks Suzanne Kuo
Commercial Process Readiness, Troubleshooting and Improvements (13:45 - 17:00) Marion Piquet, Eric Fallon
Commercial Process Readiness, Troubleshooting and Improvements : Data Mining with Avastin® for Process Improvements and Optimization Eric Fallon
Commercial Process Readiness, Troubleshooting and Improvements : Efficient Cell Culture Characterization and Validation Studies Using a Scale-down Model for Changes to a Licensed Antibody Process Marion Piquet
Recovery & Purification: Chairperson's Remarks Chris Dowd
September 17, 2007 Optimizing Cell Culture Development (Sep17-18) Fractionation and Characterization of a Peptone Used in CHO Cell Culture Processes (14:30-15:00) Masaru Shiratori
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.